JP2022513021A5 - - Google Patents
Info
- Publication number
- JP2022513021A5 JP2022513021A5 JP2021525809A JP2021525809A JP2022513021A5 JP 2022513021 A5 JP2022513021 A5 JP 2022513021A5 JP 2021525809 A JP2021525809 A JP 2021525809A JP 2021525809 A JP2021525809 A JP 2021525809A JP 2022513021 A5 JP2022513021 A5 JP 2022513021A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic peptide
- amino acid
- peptide according
- antigen
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18205615.0 | 2018-11-12 | ||
| EP18205611.9 | 2018-11-12 | ||
| EP18205615 | 2018-11-12 | ||
| EP18205611 | 2018-11-12 | ||
| PCT/EP2019/080929 WO2020099356A2 (en) | 2018-11-12 | 2019-11-12 | Immunogenic peptides with improved oxidoreductase motifs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513021A JP2022513021A (ja) | 2022-02-07 |
| JP2022513021A5 true JP2022513021A5 (cg-RX-API-DMAC7.html) | 2022-11-22 |
Family
ID=68655497
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525806A Pending JP2022513019A (ja) | 2018-11-12 | 2019-11-12 | 新規の酸化還元酵素モチーフを有する免疫原性ペプチド |
| JP2021525809A Pending JP2022513021A (ja) | 2018-11-12 | 2019-11-12 | 向上した酸化還元酵素モチーフを有する免疫原性ペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525806A Pending JP2022513019A (ja) | 2018-11-12 | 2019-11-12 | 新規の酸化還元酵素モチーフを有する免疫原性ペプチド |
Country Status (18)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008017517A1 (en) | 2006-08-11 | 2008-02-14 | Life Sciences Research Partners Vzw | Immunogenic peptides and their use in immune disorders |
| GB201418433D0 (en) | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| JP7102430B2 (ja) | 2017-03-09 | 2022-07-19 | アンシス・エスア | 糖尿病の治療のためのペプチド及び方法 |
| US20210401976A1 (en) * | 2018-11-12 | 2021-12-30 | Imcyse Sa | Immunogenic peptides with improved oxidoreductase motifs |
| EP4146255A1 (en) * | 2020-05-06 | 2023-03-15 | Imcyse SA | Immunogenic peptides with new oxidoreductase motifs |
| US20240189404A1 (en) * | 2020-05-06 | 2024-06-13 | Imcyse Sa | Immunogenic peptides with extended oxidoreductase motifs |
| IL308571A (en) | 2021-05-26 | 2024-01-01 | Imcyse Sa | Methods of treating or preventing autoimmune diseases |
| AR126654A1 (es) * | 2021-06-29 | 2023-11-01 | Imcyse Sa | Péptidos y métodos para el tratamiento de neuromielitis óptica |
| CN121226493A (zh) * | 2025-06-12 | 2025-12-30 | 杭州湃肽生化科技有限公司 | 一种双环肽化合物的应用 |
| CN122405451A (zh) * | 2026-06-22 | 2026-07-17 | 湖南师范大学 | 一种草酸青霉工程菌及其构建方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004520803A (ja) * | 2000-04-21 | 2004-07-15 | コリクサ コーポレイション | 尋常性挫瘡の治療および診断のための組成物および方法 |
| WO2003055981A2 (en) * | 2001-12-21 | 2003-07-10 | University Of Rochester | Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions |
| JP2005533855A (ja) * | 2002-07-24 | 2005-11-10 | インターツェル・アクチェンゲゼルシャフト | 病原性ウイルスからの別のリーディングフレームによりコードされる抗原 |
| WO2008017517A1 (en) * | 2006-08-11 | 2008-02-14 | Life Sciences Research Partners Vzw | Immunogenic peptides and their use in immune disorders |
| EP2245059B1 (en) | 2008-02-14 | 2017-09-20 | Life Sciences Research Partners VZW | Cd4+ t-cells with cytolytic properties |
| WO2009101206A2 (en) | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Strategies to prevent and/or treat immune responses to soluble allofactors |
| EP2106803A1 (en) * | 2008-04-04 | 2009-10-07 | Fondazione Centro San Raffaele del Monte Tabor | Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients |
| US10023847B2 (en) * | 2010-11-25 | 2018-07-17 | Imnate Sarl | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination |
| GB201201511D0 (en) * | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
| GB201309469D0 (en) * | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| GB201418433D0 (en) * | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| WO2017182528A1 (en) * | 2016-04-19 | 2017-10-26 | Imcyse Sa | Novel immunogenic cd1d binding peptides |
| EP3388447A1 (en) * | 2017-04-14 | 2018-10-17 | Imnate Sarl | Methods to produce peptides, polypeptides or cells for modulating immunity |
| US20210401976A1 (en) * | 2018-11-12 | 2021-12-30 | Imcyse Sa | Immunogenic peptides with improved oxidoreductase motifs |
| US20240189404A1 (en) * | 2020-05-06 | 2024-06-13 | Imcyse Sa | Immunogenic peptides with extended oxidoreductase motifs |
-
2018
- 2018-11-12 US US17/292,893 patent/US20210401976A1/en active Pending
-
2019
- 2019-11-12 WO PCT/EP2019/080929 patent/WO2020099356A2/en not_active Ceased
- 2019-11-12 EP EP19797967.7A patent/EP3880237A2/en active Pending
- 2019-11-12 KR KR1020217017332A patent/KR20210093933A/ko not_active Withdrawn
- 2019-11-12 CU CU2021000041A patent/CU20210041A7/es unknown
- 2019-11-12 US US17/292,888 patent/US20220288179A1/en not_active Abandoned
- 2019-11-12 AU AU2019377983A patent/AU2019377983B2/en active Active
- 2019-11-12 AU AU2019379760A patent/AU2019379760A1/en not_active Abandoned
- 2019-11-12 CN CN201980074437.0A patent/CN113015541A/zh active Pending
- 2019-11-12 JP JP2021525806A patent/JP2022513019A/ja active Pending
- 2019-11-12 CA CA3118620A patent/CA3118620A1/en active Pending
- 2019-11-12 BR BR112021009210-2A patent/BR112021009210A2/pt not_active IP Right Cessation
- 2019-11-12 EP EP19797966.9A patent/EP3880236A2/en not_active Withdrawn
- 2019-11-12 JP JP2021525809A patent/JP2022513021A/ja active Pending
- 2019-11-12 PE PE2021000701A patent/PE20211494A1/es unknown
- 2019-11-12 MX MX2021005540A patent/MX2021005540A/es unknown
- 2019-11-12 TW TW108141034A patent/TW202043255A/zh unknown
- 2019-11-12 SG SG11202104875XA patent/SG11202104875XA/en unknown
- 2019-11-12 WO PCT/EP2019/080925 patent/WO2020099352A2/en not_active Ceased
- 2019-11-12 CA CA3118981A patent/CA3118981A1/en active Pending
- 2019-11-12 CN CN201980074481.1A patent/CN113015542A/zh active Pending
-
2021
- 2021-04-30 ZA ZA2021/02909A patent/ZA202102909B/en unknown
- 2021-05-02 IL IL282849A patent/IL282849A/en unknown
- 2021-05-12 PH PH12021551101A patent/PH12021551101A1/en unknown
- 2021-05-28 CO CONC2021/0007060A patent/CO2021007060A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022513019A5 (cg-RX-API-DMAC7.html) | ||
| CN103261218B (zh) | 免疫原性肽在预防和/或治疗疾病中的应用 | |
| DK1581174T3 (en) | Yeast-based vaccines such as immunotherapy | |
| ES2328025T3 (es) | Mejoramiento de las respuestas inmunitarias por anticuerpos agonistas 4-1 bb. | |
| KR102228843B1 (ko) | Cd4+ t-세포 반응의 증강을 위한 변형된 에피토프 | |
| ES2676630T3 (es) | Control inmunogénico de tumores y células tumorales | |
| JP5709264B2 (ja) | ワクチン組成物および方法 | |
| RU2017111657A (ru) | Новые иммуногенные пептиды | |
| EP2736527A1 (en) | Dendritic cell (dc)-vaccine therapy for pancreatic cancer | |
| EP2547360A1 (en) | System and method of preparing and storing activated mature dendritic cells | |
| EP3715359A1 (en) | Cd4 helper t cell epitope fusion peptide and vaccine therewith | |
| Milani et al. | Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity | |
| WO2000003732A1 (fr) | Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, procede de preparation et applications pharmaceutiques ou vaccinales | |
| US20250009825A1 (en) | Lysates of recombinant yeast for inducing cellular immune responses | |
| Voskens et al. | Synthetic peptide-based cancer vaccines: lessons learned and hurdles to overcome | |
| WO2019210782A1 (zh) | 辅助性表位肽及其应用 | |
| RU2021115718A (ru) | Иммуногенные пептиды с улучшенными мотивами оксидоредуктазы | |
| Shihab et al. | Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine | |
| JP2016534042A (ja) | ユビキチニル化タンパク質 | |
| US10849967B2 (en) | Nucleic acid molecules encoding for chimeric CSPG4 proteins and therapeutic uses thereof | |
| Clark | Immunotherapeutic strategies in chronic myeloid leukemia | |
| Hiroshi et al. | A Novel Hydrophobized Polysaccharide/Oncoprotein Complex Vaccine for Her2 Gene Expressing Cancer | |
| AU7909700A (en) | New lymphocytes, a process for preparing the same and their use in therapeutics | |
| CA3167346A1 (en) | Vaccine and methods for detecting and preventing filariasis | |
| LeClair et al. | Induction of CD1-Restricted Immune |